OT202

· Ocumension Therapeutics (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OT202, covering 2024-05-30 to 2024-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of OT202 in Treating Moderate to Severe Dry Eye [Phase 2]